[go: up one dir, main page]

CO5510023A1 - Uso de antagonistas del canal de sodio neuronal para el control de ectoparasitos en animales homeotermicos - Google Patents

Uso de antagonistas del canal de sodio neuronal para el control de ectoparasitos en animales homeotermicos

Info

Publication number
CO5510023A1
CO5510023A1 CO03093177A CO03093177A CO5510023A1 CO 5510023 A1 CO5510023 A1 CO 5510023A1 CO 03093177 A CO03093177 A CO 03093177A CO 03093177 A CO03093177 A CO 03093177A CO 5510023 A1 CO5510023 A1 CO 5510023A1
Authority
CO
Colombia
Prior art keywords
alkyl
alkoxy
integer
optionally substituted
sodium channel
Prior art date
Application number
CO03093177A
Other languages
English (en)
Inventor
Heaney Katheleen
Susan Joan Dunney
Douglas Rugg
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CO5510023A1 publication Critical patent/CO5510023A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/34Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/38Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< where at least one nitrogen atom is part of a heterocyclic ring; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica la cual comprende un portador farmacéuticamente aceptable y una cantidad ectoparasiticidamente efectiva de un antagonista del canal de sodio neuronal. La composición de acuerdo con la reivindicación 1, en donde dicho antagonista del canal de sodio neuronal es un compuesto de fórmula I, II o III<EMI FILE="03093177_1" ID="1" IMF=JPEG >en donde A es CR4R5 o NR6;W es O o S;X. Y, Z, XAND#39, YAND#39 y ZAND#39 son cada uno independientemente H; halógeno; OH; CN; NO2, alquiloC1-C6 opcionalmente sustituido con uno o más grupos halógeno, alcoxiC1-C3, haloalcoxiC1-C3, cicloaquiloC3-C6, alqueniloxiC2-C6 o sulfoniloxi; alcoxiC1-C6 opcionalmente sustituido con uno o más grupos halógeno, alcoxiC1-C3 o cicloalquiloC3-C6;alcoxicarboniIC1-C6, cicloalquilcarboniloxiC3-C6, fenilo opcionalmente sustituido con uno o más grupos halógeno, alquiloC1-C4, o alcoxiC1-C4;aminocarboniloxi opcionalmente sustituido con uno o más grupos alquiloC1-C3;alcoxicarboniloxiC1-C6; alquilosulfoniloxiC1-C6; alqueniloC2-C6; o NR12R13;m, p y q son cada uno independientemente un entero de 1, 2, 3, 4, ó 5;n es un entero de 0, 1, ó 2;r es un entero de 1 ó 2;t es un entero de 1, 2, 3 ó 4;R, R1, R2, R3, R4 y R5 son cada uno independientemente H o alquiloC1-C4;R6 es H, alquiloC1-C6, haloalquiloC1-C6, alcoxialquiloC1-C6, alcoxiC1-C6, haloalcoxiC1-C6, alqueniloC2-C6, alquiniloC2-C6, alquilocarbonilo C1-C6, alcoxicarboniloC1-C6, alquiltioC1-C6, o haloalquiltioC1-C6; ...
CO03093177A 2002-10-21 2003-10-20 Uso de antagonistas del canal de sodio neuronal para el control de ectoparasitos en animales homeotermicos CO5510023A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41988702P 2002-10-21 2002-10-21

Publications (1)

Publication Number Publication Date
CO5510023A1 true CO5510023A1 (es) 2005-04-29

Family

ID=32069964

Family Applications (1)

Application Number Title Priority Date Filing Date
CO03093177A CO5510023A1 (es) 2002-10-21 2003-10-20 Uso de antagonistas del canal de sodio neuronal para el control de ectoparasitos en animales homeotermicos

Country Status (25)

Country Link
US (1) US7906128B2 (es)
EP (2) EP1967067A3 (es)
JP (1) JP2004143172A (es)
KR (1) KR101110579B1 (es)
CN (1) CN100531728C (es)
AR (1) AR041668A1 (es)
AT (1) ATE405161T1 (es)
AU (2) AU2003255177B2 (es)
BR (1) BR0304618A (es)
CA (1) CA2444692C (es)
CO (1) CO5510023A1 (es)
CY (1) CY1108430T1 (es)
DE (1) DE60323028D1 (es)
DK (1) DK1413201T3 (es)
ES (1) ES2311677T3 (es)
HR (1) HRP20030856A2 (es)
ME (1) ME00571A (es)
MX (1) MXPA03009595A (es)
NZ (2) NZ550771A (es)
PL (1) PL362962A1 (es)
PT (1) PT1413201E (es)
RS (1) RS51054B (es)
SI (1) SI1413201T1 (es)
TW (1) TWI311465B (es)
ZA (1) ZA200308147B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906128B2 (en) 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US7531186B2 (en) * 2003-12-17 2009-05-12 Merial Limited Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
KR100595446B1 (ko) * 2004-01-19 2006-07-03 삼성전자주식회사 디스플레이장치
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
TWI368505B (en) 2005-05-24 2012-07-21 Wyeth Corp Versatile high load concentrate compositions for control of ecto-parasites
US20100095900A1 (en) * 2005-05-24 2010-04-22 Wyeth Llc Device and method for controlling insects
US7749527B2 (en) * 2005-05-24 2010-07-06 Wyeth Llc Gel compositions for control of ecto-parasites
US20060293260A1 (en) * 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
TW200846029A (en) * 2007-02-09 2008-12-01 Wyeth Corp High dose, long-acting ectoparasiticide for extended control
CL2008001614A1 (es) * 2007-06-05 2008-08-08 Wyeth Corp Composicion parasiticida veterinaria que comprende un disolvente que no contiene hidroxilo, un estabilizador, amitraz y opcionalmente una lactona macrociclica y miristato de isopropilo; y su uso para tratar o controlar una infestacion o infeccion par
NZ592865A (en) 2008-11-19 2013-08-30 Merial Ltd Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
US9173728B2 (en) 2008-11-19 2015-11-03 Merial Inc. Multi-cavity container having offset indentures for dispensing fluids
AU2010224685A1 (en) 2009-03-18 2011-11-03 Fidopharm, Inc. Parasiticidal formulation
ES2908094T5 (en) * 2010-12-27 2025-08-12 Intervet Int Bv Topical localized isoxazoline formulation
EP2916810A4 (en) 2012-10-16 2016-06-01 Solano S P Ltd TOPICAL FORMULATIONS FOR THE TREATMENT OF PARASITIC INFESTATIONS
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CN105168560A (zh) * 2015-07-22 2015-12-23 贵州谷丰生态农业发展有限责任公司 一种从鹅耳孔驱赶虱子的方法
US10512628B2 (en) 2016-04-24 2019-12-24 Solano S.P. Ltd. Dinotefuran liquid flea and tick treatment
CN119157876A (zh) 2017-12-15 2024-12-20 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1176167A (en) 1980-03-06 1984-10-16 John J. Windheuser Use of n,n-diethyl-m-toluamide for enhancing skin permeation of bio-affecting agents
US4560553A (en) 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
GB8525447D0 (en) 1985-10-16 1985-11-20 Fbc Ltd Pesticidal compositions
US5116850A (en) 1987-11-30 1992-05-26 E. I. Du Pont De Nemours And Co. Heterocyclic pyrazoline carboxanilides
ES2089056T3 (es) 1990-06-16 1996-10-01 Nihon Nohyaku Co Ltd Derivados de hidrazincarboxamida, un procedimiento para la produccion de los mismos, y usos de los mismos.
EP0553284A1 (en) 1990-10-05 1993-08-04 E.I. Du Pont De Nemours And Company Semicarbazone arthropodicides
US5304573A (en) 1990-11-17 1994-04-19 Nihon Nohyaku Co., Ltd. Hydrazone derivatives, processes for production thereof, and uses thereof
US5462938A (en) 1990-12-21 1995-10-31 Annus; Gary D. Arthropodicidal oxadiazinyl, thiadiazinyl and triazinyl carboxanilides
US5250532A (en) 1991-04-11 1993-10-05 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides
JPH07165697A (ja) 1993-10-04 1995-06-27 Nissan Chem Ind Ltd セミカルバゾン化合物及び有害生物防除剤
JP3711581B2 (ja) 1995-03-31 2005-11-02 日産化学工業株式会社 セミカルバゾン誘導体及び有害生物防除剤
JPH09301947A (ja) 1996-05-17 1997-11-25 Nissan Chem Ind Ltd セミカルバゾン誘導体及び有害生物防除剤
US5968990A (en) 1997-10-14 1999-10-19 Isp Investments Inc. Water-dilutable, microemulsion concentrate and pour-on formulations thereof
JP4239298B2 (ja) * 1998-07-27 2009-03-18 住友化学株式会社 動物の外部寄生虫防除剤
WO2000029387A1 (en) * 1998-11-12 2000-05-25 Sagami Chemical Research Center 2-anilino-4(3h)-pyrimidinone derivatives, intermediates in the production thereof, process for producing the same and pesticides containing the same as the active ingredient
US5965137A (en) * 1998-11-16 1999-10-12 Advanced Medical Instruments Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases
DE60024826T2 (de) * 1999-03-12 2006-06-14 Basf Ag Synergistische insektizide zusammensetzungen
MY138864A (en) 1999-07-05 2009-08-28 Nihon Nohyaku Co Ltd Ant controllers and method for application thereof
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
JP2001240583A (ja) * 1999-12-17 2001-09-04 Mitsubishi Chemicals Corp ジハロプロペニルオキシベンゼン誘導体及びこれを有効成分とする有害生物防除剤
JP2001240541A (ja) * 2000-03-02 2001-09-04 Kanto Kachiku Rinsho Center:Kk 動物外部寄生虫の駆除方法及び駆除剤
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
IL143225A (en) * 2000-05-24 2008-03-20 Pfizer Preparation of drugs containing α-amylase inhibitors to treat hyperacidity of the inner abdomen
JP5093429B2 (ja) * 2000-10-18 2012-12-12 日本農薬株式会社 動物用外部寄生性害虫防除剤及びその使用方法
US7906128B2 (en) 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US20040122075A1 (en) 2002-12-16 2004-06-24 Wyeth N-phenyl-3-cyclopropylpyrazole-4-carbonitriles as ectoparasiticidal agents
EP1773121B1 (en) 2004-07-06 2011-02-09 Basf Se Liquid pesticide compositions
TWI350728B (en) 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions

Also Published As

Publication number Publication date
YU82503A (sh) 2006-05-25
EP1967067A3 (en) 2009-05-06
ZA200308147B (en) 2005-04-20
DE60323028D1 (de) 2008-10-02
TW200418388A (en) 2004-10-01
DK1413201T3 (da) 2008-11-10
AU2009210409A1 (en) 2009-09-10
EP1413201A3 (en) 2004-06-23
BR0304618A (pt) 2004-08-31
MXPA03009595A (es) 2004-10-15
AR041668A1 (es) 2005-05-26
SI1413201T1 (sl) 2008-12-31
CA2444692C (en) 2012-01-10
TWI311465B (en) 2009-07-01
ES2311677T3 (es) 2009-02-16
EP1413201A2 (en) 2004-04-28
CN1496736A (zh) 2004-05-19
HRP20030856A2 (en) 2005-02-28
CY1108430T1 (el) 2014-04-09
ME00571A (en) 2011-12-20
AU2003255177A1 (en) 2004-05-06
ATE405161T1 (de) 2008-09-15
US7906128B2 (en) 2011-03-15
KR20040034542A (ko) 2004-04-28
PT1413201E (pt) 2008-10-28
JP2004143172A (ja) 2004-05-20
CN100531728C (zh) 2009-08-26
NZ550771A (en) 2008-06-30
EP1967067A2 (en) 2008-09-10
RS51054B (sr) 2010-10-31
PL362962A1 (en) 2004-05-04
NZ567277A (en) 2009-12-24
AU2003255177B2 (en) 2009-10-08
US20040116419A1 (en) 2004-06-17
CA2444692A1 (en) 2004-04-21
KR101110579B1 (ko) 2012-02-15
EP1413201B1 (en) 2008-08-20

Similar Documents

Publication Publication Date Title
CO5510023A1 (es) Uso de antagonistas del canal de sodio neuronal para el control de ectoparasitos en animales homeotermicos
ES2531256T3 (es) Amidas fungicidas
CO5611147A2 (es) Derivados de nicotinamida utiles como inhibidores p38
ECSP067013A (es) 2-quinolil-oxazoles sustituidos útiles como inhibidores de pde4
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
CO6270320A2 (es) Derivados de piperidina utiles como antagonistas del receptor orexina
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
NO20022683L (no) Ureaforbindelser med muskarinisk reseptor-antagonistaktivitet
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
PE20080253A1 (es) Antagonistas de los receptores cgrp monociclicos sustituidos
AR049652A1 (es) Sales cuaternarias antagonistas del receptor ccr2
HRP20080666T3 (en) Cgrp receptor antagonists
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
HRP20100194T8 (hr) Perikondenzirani triciklički spojevi, korisni kao antibakterijska sredstva
AR040278A1 (es) Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos
MY136824A (en) Substituted benzoxazinones and uses thereof
AR084486A1 (es) Compuestos de imina
DK1636221T3 (da) 3-Heterocyclyl-azetidin-forbindelser, som er nytte som NK1/NK2 receptorantagonister
AR079206A1 (es) Composiciones herbicidas
BRPI0417943A (pt) antagonistas de receptor de crf e métodos relacionados para essa finalidade
MX2010012421A (es) 5-[5-[2-(3,5-bis(trifluormetil)fenil)-2-metilpropanoilmetilamino] -4-(4-fluoro-2-metilfenil)]-2-piridinil-2-alquil-prolinamida como antagosnistas del receptor de neurocinina 1.
PE20070069A1 (es) Piperazin-piperidinas como antagonistas y agonistas del receptor 5-ht1a
DE602005009977D1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
CO4770917A1 (es) Compuestos de dihalopropeno, su uso e intermedios para su produccion
AR037611A1 (es) Compuestos derivados de amino-tetralina, su uso, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden

Legal Events

Date Code Title Description
FC Application refused